Search Results

There are 196603 results for: content related to: Description of Parkinson's Disease as a Clinical Syndrome

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  3. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  4. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  5. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  6. You have free access to this content
    Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 22, Issue S16, 2007, Pages: S1–S325,

    Version of Record online : 24 APR 2007, DOI: 10.1002/mds.21535

  7. You have full text access to this OnlineOpen article
    Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 94–105, Ahmed A. Othman and Sandeep Dutta

    Version of Record online : 20 JUN 2014, DOI: 10.1111/bcp.12324

  8. Levodopa

    Movement Disorders

    Volume 17, Issue S4, July/August 2002, Pages: S23–S37,

    Version of Record online : 29 JUL 2002, DOI: 10.1002/mds.5558

  9. Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial

    European Journal of Neurology

    Volume 19, Issue 6, June 2012, Pages: 820–826, D. Nyholm, A. Johansson, H. Lennernäs and H. Askmark

    Version of Record online : 5 DEC 2011, DOI: 10.1111/j.1468-1331.2011.03614.x

  10. Levodopa in the treatment of Parkinson’s disease

    European Journal of Neurology

    Volume 16, Issue 9, September 2009, Pages: 982–989, A. H. V. Schapira, M. Emre, P. Jenner and W. Poewe

    Version of Record online : 15 JUN 2009, DOI: 10.1111/j.1468-1331.2009.02697.x

  11. Parkinson's Disease

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt084

  12. Levodopa/DDCI and entacapone is the preferred treatment for Parkinson’s disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort

    European Journal of Neurology

    Volume 15, Issue 7, July 2008, Pages: 643–648, P. Damier, F. Viallet, M. Ziegler, I. Bourdeix and K. Rerat

    Version of Record online : 10 JUN 2008, DOI: 10.1111/j.1468-1331.2008.02165.x

  13. Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight

    European Journal of Neurology

    Volume 15, Issue 5, May 2008, Pages: 493–496, J. C. Sharma, I.N. Ross, O. Rascol and D. Brooks

    Version of Record online : 18 MAR 2008, DOI: 10.1111/j.1468-1331.2008.02106.x

  14. Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcapone

    Clinical Pharmacology & Therapeutics

    Volume 67, Issue 6, June 2000, Pages: 610–620, Karin Jorga, Ludger Banken, Bärbel Fotteler, Paul Snell and Jean-Louis Steimer

    Version of Record online : 15 JUN 2000, DOI: 10.1067/mcp.2000.106795

  15. Dyskinesia Induced by Levodopa and Dopamine Agonists in Patients with Parkinson's Disease

    Drug Induced Movement Disorders, Second Edition

    John G. Nutt, Matthew A. Brodsky, Pages: 313–350, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753217.ch13

  16. Large differences in levodopa dose requirement in Parkinson’s disease: men use higher doses than women

    European Journal of Neurology

    Volume 17, Issue 2, February 2010, Pages: 260–266, D. Nyholm, E. Karlsson, M. Lundberg and H. Askmark

    Version of Record online : 18 DEC 2009, DOI: 10.1111/j.1468-1331.2009.02866.x

  17. Motor features and response to oral levodopa in patients with Parkinson’s disease under continuous dopaminergic infusion or deep brain stimulation

    European Journal of Neurology

    Volume 19, Issue 1, January 2012, Pages: 76–83, A. E. Elia, C. Dollenz, P. Soliveri and A. Albanese

    Version of Record online : 4 JUN 2011, DOI: 10.1111/j.1468-1331.2011.03437.x

  18. Levodopa for the treatment of restless legs syndrome

    Intervention Review

    The Cochrane Library

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Published Online : 15 FEB 2011, DOI: 10.1002/14651858.CD005504.pub2

  19. You have free access to this content
    Pharmacokinetics of levodopa/benserazide versus levodopa/carbidopa in healthy subjects and patients with Parkinson's disease

    Neurology and Clinical Neuroscience

    Volume 3, Issue 2, March 2015, Pages: 68–73, Hirotaka Iwaki, Noriko Nishikawa, Masahiro Nagai, Tomoaki Tsujii, Hayato Yabe, Madoka Kubo, Ichiro Ieiri and Masahiro Nomoto

    Version of Record online : 8 DEC 2014, DOI: 10.1111/ncn3.152

  20. Poster session 2, Abstracts 345–694

    Movement Disorders

    Volume 19, Issue S9, 2004, Pages: S129–S244,

    Version of Record online : 10 MAY 2004, DOI: 10.1002/mds.20176